TNDM:NASDAQ
Tandem Diabetes Care Inc
16,26 US$
arrow_upward
+0,62%(+0,10) 1D
7 tet, 9:39:24 p.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për TNDM...
Hap
15,80 US$
I lartë
16,36 US$
I ulët
15,80 US$
Kapitalizimi i tregut
1,13 mld
Vëllimi mesatar
1,95 mln
Vëllimi
8,28 mijë
Maksimumi 52-javor
29,65 US$
Minimumi 52-javor
12,26 US$
Fitimet për aksion
-0,93 US$
Beta
1,66
Aksionet në qarkullim
69,58 mln
Numri i punonjësve
2 mijë
Hap
15,80 US$
I lartë
16,36 US$
I ulët
15,80 US$
Kapitalizimi i tregut
1,13 mld
Vëllimi mesatar
1,95 mln
Vëllimi
8,28 mijë
Maksimumi 52-javor
29,65 US$
Minimumi 52-javor
12,26 US$
Fitimet për aksion
-0,93 US$
Beta
1,66
Aksionet në qarkullim
69,58 mln
Numri i punonjësve
2 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
https://www.dars.gov.et/
·
6 ditë më parë
Tandem Diabetes Care (TNDM) Slips 0.84% to $16.43 as Traders Watch Support at $15.61 - High Volume Node
Profili
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
Rreth Tandem Diabetes Care Inc
Drejtori ekzekutivJohn Sheridan
Punonjësit2,5 mijë
Themeluar mëjan 2006
Selia-
SektoriMedical device
Uebsajtitandemdiabetes.com